Healthcare provider profile · identity verified

David Grace, MD

Internal Medicine · PALMETTO, FL · NPI 1740275577

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	345	116
Levothyroxine Sodium	Levothyroxine Sodium	267	93
Lisinopril	Lisinopril	238	78
Amlodipine Besylate	Amlodipine Besylate	230	82
Pantoprazole Sodium	Pantoprazole Sodium	189	67
Losartan Potassium	Losartan Potassium	186	65
Rosuvastatin Calcium	Rosuvastatin Calcium	155	60
Metformin Hcl	Metformin Hcl	151	53
Albuterol Sulfate Hfa	Albuterol Sulfate	144	44
Simvastatin	Simvastatin	140	47
Doxycycline Hyclate	Doxycycline Hyclate	139	79
Alprazolam	Alprazolam	136	59
Omeprazole	Omeprazole	136	53
Metoprolol Tartrate	Metoprolol Tartrate	123	37
Diclofenac Sodium	Diclofenac Sodium	121	38
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	113	38
Tamsulosin Hcl	Tamsulosin Hcl	109	38
Gabapentin	Gabapentin	104	46
Meloxicam	Meloxicam	103	37
Trazodone Hcl	Trazodone Hcl	100	37
Furosemide	Furosemide	98	37
Allopurinol	Allopurinol	94	29
Metoprolol Succinate	Metoprolol Succinate	94	34
Hydrochlorothiazide	Hydrochlorothiazide	82	30
Ciprofloxacin Hcl	Ciprofloxacin Hcl	80	37
Clopidogrel	Clopidogrel Bisulfate	78	26
Montelukast Sodium	Montelukast Sodium	71	22
Atenolol	Atenolol	69	28
Methylprednisolone	Methylprednisolone	68	37
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	67	19
Duloxetine Hcl	Duloxetine Hcl	66	17
Eliquis	Apixaban	66	22
Glipizide	Glipizide	62	19
Glimepiride	Glimepiride	54	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	51	21
Potassium Chloride	Potassium Chloride	51	14
Ropinirole Hcl	Ropinirole Hcl	50	13
Ozempic	Semaglutide	49	14
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	48	14
Tramadol Hcl	Tramadol Hcl	44	21
Azithromycin	Azithromycin	43	24
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	43	14
Pravastatin Sodium	Pravastatin Sodium	43	20
Levofloxacin	Levofloxacin	41	26
Xarelto	Rivaroxaban	39	suppressed
Celecoxib	Celecoxib	38	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	38	15
Sertraline Hcl	Sertraline Hcl	37	15
Estradiol	Estradiol	36	15
Sumatriptan Succinate	Sumatriptan Succinate	35	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	34	16
Bupropion Xl	Bupropion Hcl	33	11
Janumet	Sitagliptin Phos/Metformin Hcl	33	suppressed
Temazepam	Temazepam	33	16
Lorazepam	Lorazepam	32	14
Alendronate Sodium	Alendronate Sodium	31	11
Famotidine	Famotidine	31	12
Synthroid	Levothyroxine Sodium	31	suppressed
Carvedilol	Carvedilol	30	14
Jardiance	Empagliflozin	30	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	12
Valsartan	Valsartan	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	29	14
Fluticasone Propionate	Fluticasone Propionate	28	14
Quetiapine Fumarate	Quetiapine Fumarate	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	11
Warfarin Sodium	Warfarin Sodium	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	26	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	25	suppressed
Ibuprofen	Ibuprofen	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Memantine Hcl	Memantine Hcl	24	suppressed
Ondansetron Odt	Ondansetron	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	11
Donepezil Hcl	Donepezil Hcl	23	suppressed
Prednisone	Prednisone	23	12
Ezetimibe	Ezetimibe	22	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	21	suppressed
Fenofibrate	Fenofibrate	21	suppressed
Spironolactone	Spironolactone	21	suppressed
Finasteride	Finasteride	20	suppressed
Levetiracetam	Levetiracetam	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Diazepam	Diazepam	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	18	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Lovastatin	Lovastatin	18	suppressed
Metronidazole	Metronidazole	18	suppressed
Mirtazapine	Mirtazapine	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Paroxetine Hcl	Paroxetine Hcl	18	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	18	suppressed
Myrbetriq	Mirabegron	17	suppressed
Clonazepam	Clonazepam	16	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Oxycodone Hcl	Oxycodone Hcl	16	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	16	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	15	suppressed
Clobetasol Propionate	Clobetasol Propionate	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Valacyclovir	Valacyclovir Hcl	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Carisoprodol	Carisoprodol	13	suppressed
Meclizine Hcl	Meclizine Hcl	13	suppressed
Pregabalin	Pregabalin	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Azelastine Hcl	Azelastine Hcl	12	suppressed
Colchicine	Colchicine	12	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Cilostazol	Cilostazol	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error